Enflurane in anaesthesiological practice.
Enflurane was given as the principal inhalatory agent in general anaesthesia in 75 patients aged from 17 to 55 years for gynaecological operations. Anaesthesia was conducted with muscle relaxation administering the drug in concentration of 0.2-1% vol. (mean maintenance concentration 0.6%). No cardiovascular, hepatic and renal disturbances were observed. The serum glucose level increased by a mean value of 64.8% during enflurance anaesthesia, however, it did not cross the renal threshold. Enflurane failed to ensure postoperative analgesia. The drug may be used as a valuable supplement to the presently used anaesthetic agents.
D000293:Adolescent; D000328:Adult; D000698:Analgesia; D000768:Anesthesia, General; D001285:Atropine; D001786:Blood Glucose / Q000032:analysis; D004341:Drug Evaluation; D004737:Enflurane / Q000592:standards*; D005260:Female; D006801:Humans; D008614:Meperidine; D008738:Methyl Ethers / Q000592:standards*; D008875:Middle Aged; D009126:Muscle Relaxation; D011292:Premedication; D011398:Promethazine; D014403:Tubocurarine
D001786:Blood Glucose; D008738:Methyl Ethers; D001285:Atropine; D004737:Enflurane; D008614:Meperidine; D011398:Promethazine; D014403:Tubocurarine